T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
MS Money Moves
by
5h ago
LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driven health care performance improvement company in the United States, has been extended through March 31, 2025. The products covered under the contract with Vizient include the T2Dx® Instrument, the T2Bacteria® Panel and the T2Candida® Panel, which detect sepsis-causing bacterial and fungal pathogens di ..read more
Visit website
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
MS Money Moves
by
6h ago
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data from collaborators at the University of Michigan utilizing its groundbreaking inFoods IBS technologies will be presented in the IBS Clinical Session at the 2024 Digestive Disease Week (DDW) Annual Meeting in Washington DC. DDW is renowned as the world's premier scientific and clinical meeting for digestive disease health care professionals. The post Biomerica InFoods IBS Data to be Presented at the ..read more
Visit website
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
MS Money Moves
by
6h ago
CHAPEL HILL, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced full year 2023 financial results, and provided clinical development and business updates. The post Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results appeared first on Bio Tech Winners ..read more
Visit website
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
MS Money Moves
by
6h ago
SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the appointment of Geoff McDonough, M.D., to its Board of Directors. The post Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors appeared first on Bio Tech Winners ..read more
Visit website
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
MS Money Moves
by
6h ago
Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital The post CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors appeared first on Bio Tech Winners ..read more
Visit website
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
MS Money Moves
by
6h ago
TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer The post TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer appeared first on Bio Tech Winners ..read more
Visit website
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
MS Money Moves
by
7h ago
Pluri’s business verticals leverage Company’s world-leading 3D cell expansion know-how, IP, and manufacturing facility to drive revenue and bring innovative cell-based solutions to numerous industries Pluri’s business verticals leverage Company’s world-leading 3D cell expansion know-how, IP, and manufacturing facility to drive revenue and bring innovative cell-based solutions to numerous industries The post Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences appeared first on Bio Tech Winners ..read more
Visit website
Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics
MS Money Moves
by
7h ago
ANN ARBOR, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI"). The post Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics appeared first on Bio Tech Winners ..read more
Visit website
Affimed Reports 2023 Financial Results and Operational Progress
MS Money Moves
by
7h ago
MANNHEIM, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today reported financial results and provided an update on clinical and corporate progress for the year ended December 31, 2023. The post Affimed Reports 2023 Financial Results and Operational Progress appeared first on Bio Tech Winners ..read more
Visit website
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
MS Money Moves
by
12h ago
Planegg/Martinsried, March 28, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the fiscal year ended December 31, 2023, and provided a corporate update. The post Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update appeared first on Bio Tech Winners ..read more
Visit website

Follow MS Money Moves on FeedSpot

Continue with Google
Continue with Apple
OR